Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-19-004161
Filing Date
2019-03-29
Accepted
2019-03-29 06:16:20
Documents
101
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm 10-K 1595828
2 image_001.jpg GRAPHIC 40476
3 ex23-1.htm EX-23.1 6344
4 ex23-2.htm EX-23.2 5553
5 ex31-1.htm EX-31.1 10582
6 ex31-2.htm EX-31.2 10386
7 ex32-1.htm EX-32.1 9374
  Complete submission text file 0001493152-19-004161.txt   8090706

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE FILE mbii-20181231.xml EX-101.INS 1418591
9 XBRL SCHEMA FILE mbii-20181231.xsd EX-101.SCH 90033
10 XBRL CALCULATION FILE mbii-20181231_cal.xml EX-101.CAL 88820
11 XBRL DEFINITION FILE mbii-20181231_def.xml EX-101.DEF 398653
12 XBRL LABEL FILE mbii-20181231_lab.xml EX-101.LAB 624619
13 XBRL PRESENTATION FILE mbii-20181231_pre.xml EX-101.PRE 518475
Mailing Address 1540 DREW AVENUE DAVIS CA 95618
Business Address 1540 DREW AVENUE DAVIS CA 95618 530-750-2800
MARRONE BIO INNOVATIONS INC (Filer) CIK: 0001441693 (see all company filings)

EIN.: 205137161 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36030 | Film No.: 19713790
SIC: 2870 Agricultural Chemicals